# Designing multi-epitope based peptide vaccine candidates against SARS-CoV-2 using immunoinformatics approach
> Ysrafil Y.

URL kanonis: https://discover.unhas.ac.id/publications/designing-multi-epitope-based-peptide-vaccine-candidates-against-sars-cov-2-usin
Jurnal / Konferensi: Bioimpacts
Tahun terbit: 2022
DOI: https://doi.org/10.34172/bi.2022.23769
Kuartil SJR: Q2
Citations: 19

## Authors
- Ysrafil Y.

## Abstract
<i><b>Introduction:</b> </i> The current incidence of the novel coronavirus disease has shown only small reductions of cases and has become a major public health challenge. Development of effective vaccines against the virus is still being encouraged such as multi-epitope vaccines designed from the components of SARS-CoV-2 including its spike, nucleocapsid and ORF1a proteins. Since the addition of adjuvants including HABA protein and L7/L12 ribosomal are considered helpful to increase the effectiveness of the designed vaccine, we proposed to design multiepitope vaccines by two different adjuvants. <i><b>Methods:</b> </i> We used the IEDB server to predict BCL and TCL epitopes that were characterized using online tools including VaxiJen, AllPred and IL-10 Prediction. The selected epitopes were further constructed into multiepitope vaccines. We also added two different adjuvants to the vaccine components in order to increase the effectiveness of the vaccines. The 3D-structured vaccines were built using trRosetta. They were further docked with different Toll-like-receptors (TLR 3, 4 and 8) and the entry receptor of SARS-CoV-2, ACE2 using ClusPro, PatchDock and refined by FireDock. All structures were visualized by USCF Chimera and PyMOL. <i><b>Results:</b> </i> In this study, we succeeded in designing two different candidate vaccines by the addition of HABA protein and L7/L12 ribosomal as adjuvants. The two vaccines were almost equally good in terms of their physicochemical properties and characteristics. Likewise, their strong interactions with TLR3 4, 8 and ACE2 show the lowest energy level of both was estimated at more than -1,000. Interactions of vaccines with ACE2 and TLRs are essential for activation of immune responses and production of antibodies. <i><b>Conclusion:</b> </i> The two designed and constructed multiepitope vaccine have good characteristics and may have the potential to activate humoral and cellular immune responses against SARS-CoV-2. Further research is worth considering to confirm the findings of this study.

## Keywords
- Epitope
- Virology
- Biology
- Computational biology
- Peptide vaccine
- Antibody
- Immunology

---
Sumber: Discover Unhas — RIMS Universitas Hasanuddin.
Saat mengutip, gunakan DOI bila tersedia atau URL kanonis di atas.